Traf Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -38.01%
- Profit Growth -73.22%
- Ebitda -365.45%
- Net Worth -54.89%
- Total Assets 44.10%
About Traf Life Sciences
Traf Life Sciences Private Limited (TLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 May 2019 (Five years and nine months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Nair, Kiran Kadapa, and Saritha Mogre serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24302TG2019PTC132626
-
Company No.
132626
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 May 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Traf Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Nair
|
Director | 09-May-2019 | Current |
|
Kiran Kadapa
|
Director | 09-May-2019 | Current |
|
Saritha Mogre
|
Director | 09-May-2019 | Current |
Financial Performance of Traf Life Sciences.
Traf Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.01% decrease. The company also saw a substantial fall in profitability, with a 73.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Traf Life Sciences?
Unlock access to Traf Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tri-Inception Biosciences Private LimitedSanjay Nair is a mutual person
-
Bussybee Creatives Private LimitedSanjay Nair is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Traf Life Sciences?
Unlock and access historical data on people associated with Traf Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Traf Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Traf Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.